Ozempic
Ozempic Lawsuit Against Novo Nordisk Over GLP-1 Stomach Injuries
Novo Nordisk and Eli Lilly are accused of failing to warn of gastroparesis and vomiting in the Ozempic lawsuit. Claims are not open. Follow the case.
- Potential payment
- Up to $500,000
Subject to eligibility and claim terms.
- Claim deadline
- TBD
- Proof requirement
- TBD
Eligibility
Who may qualify?
Check the covered dates, products, locations, and other official terms before you file.
Case overview
What is the Ozempic case about?
A major lawsuit is unfolding against the makers of GLP-1 receptor agonist drugs, with plaintiffs claiming that medications like Ozempic and Mounjaro led to serious gastrointestinal injuries. The alleged harms include gastroparesis, intestinal blockages, and severe, persistent vomiting. According to the lawsuit, the drug makers knew of these risks but failed to adequately warn patients and misrepresented how safe the medications actually were.
Case details
- Company
- Novo Nordisk, Eli Lilly
Settlement administrator and official sources
- Listing verificationLast checked Sep 26, 2026
